Introduction
Growing evidence suggests that several single point mutations in the gene encoding the human transcription factor STAT1 (signal transducer and activator of transcription 1) result in impaired interleukin-17 (IL-17) immunity causing chronic mucocutaneous candidiasis (CMC) (Liu et al. 2011; van de Veerdonk et al. 2011; Hori et al. 2012; Takezaki et al. 2012; Aldave et al. 2013; Soltesz et al. 2013) . As recently described, gain-of-function (GOF) mutations in the human STAT1 gene not only cause CMC, but can also present with a variety of other clinical phenotypes due to immune dysregulation, such as intracellular dimorphic fungal (histoplasmosis and disseminated coccidioidomycosis), atypical mycobacterial infections and the wild-type forkhead-box protein 3 (FOXP3) immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX)-like syndrome Sampaio et al. 2013; Kumar et al. 2014; Depner et al. 2015) .
The majority of autosomal dominant, CMC-causing mutations are located at the interface between the two protomers of the antiparallel STAT1 dimer, which is formed through reciprocal binding of the coiled-coil domain of one protomer to the DNA-binding domain of its partner protomer (Zhong et al. 2005; Mertens et al., 2006; Wenta et al., 2008) . Numerous studies have established that mutations affecting the stability of the antiparallel STAT1 dimer conformation result in reduced numbers of IL-17-producing CD4 + T cells (Liu et al. 2011; Smeekens et al., 2011; van de Veerdonk et al. 2011; Takezaki et al. 2012; Soltesz et al. 2013 ). However, much less is known about the formation of regulatory T cells (Treg) in response to stimulation of cells with interferon. In this case report, we describe the clinical and laboratory findings in a STAT1-F172L mutation carrier, presenting with clinical features of CMC who exhibited low numbers of Tregs and a promoter-specific upregulation of STAT1-driven target genes.
Methods
Peripheral blood samples were taken from the patient and a healthy age-and sexmatched donor after informed consent. For phenotypic characterization, 50 µl of whole blood were incubated with antibody mixtures for 45 min and subsequently fixed and washed before analysis. The antibodies used were anti-CD3 (clone 4 OKT3), anti-CD4 (clones RPA-T4 or SK3), anti-CD8 (clone RPA-T8; eBioscience), To assess proliferation, freshly prepared PBMC were labeled with eFluor 670 (eBioscience) according to the manufacturer's protocols and cultured with 1 µg/ml soluble anti-CD3 (clone OKT3; BioXcell) and 20 U/ml of IL-2. On days 3 and 4, cells
were stained with anti-CD4 and anti-CD8 antibodies, and eFluor 670 dilution was measured by flow cytometry. All samples were analyzed in a FACS Canto II flow cytometer using the FACSDiva software (BD Biosciences) or in a Navios cytometer as for STAT1 and GAPDH were as previously described (Staab et al., 2013) . The relative expression of a transcript was normalized to the expression of GAPDH as determined for each sample. The C t -method was used to determine comparative relative expression levels. To compare gene expression data, unpaired Student's t or Mann-Whitney U tests were used, and differences were considered significant if p ≤ 0.05.
Results

Case representation
A 10-year-old boy of non-consanguineous, healthy parents was referred to our hospital because of abdominal bloating and pain, diarrhea, weight loss and fatigue.
His medical history revealed multiple Candida infections of the skin (face and limbs) and recurrent infections of the upper respiratory tract with frequent wheezing since early childhood, including one episode of hospital-treated pneumonia. Despite elevated serum gliadin IgG antibodies, endoscopy showed no histological signs of celiac disease, but severe ulcerative, microbiologically confirmed Candida albicans esophagitis. Physical examination showed severe dystrophy (height and weight below the 3 rd percentile), while endocrinological work-up showed no deficiency of growth hormone. Standardised neuropsychological tests demonstrated delayed development of speech and interllectual ability, impaired short-time memory, and a marked attention-deficit disorder.
Laboratory findings
Laboratory results included anaemia (haemoglobin 9.6 g/dL), hypogammaglobulinemia and an impaired antibody production against routine vaccinations (diphtheria and tetanus). The screening test for HIV1/2 was negative.
The patient had persisting B-cell lymphopenia with an increased proportion of naive (Fig. 1A) . In vitro T-cell assays showed that Candida antigen stimulation resulted in a decreased IFNɣ response, while the response after phorbol myristate acetate (PMA) stimulation was high in CD4 + T cells. The distribution of V beta receptor chains on CD4 + and CD8 + T cells appeared to be normal. In IFNα-and IFNɣ-stimulated monocytes from blood samples of the index patient, a significantly increased level of tyrosinephosphorylated STAT1 was observed as compared to monocytes from a healthy control (Fig. 1B) . However, the level of IL-21-induced phospho-STAT3 activation did not differ between control and patient (Fig. 1C) 
Genetic findings
Using DNA sequencing, we identified a rare de novo (parents had wild-type genotype) heterozygous mutation (c.514T>C, p.Phe172Leu) in exon 7 of the STAT1 gene, resulting in an amino acid exchange in the coiled-coil domain (Fig. 1D) .
Sanger sequencing showed no evidence of CVID-associated genetic alterations in
any of the following genes tested: BTK, IGHM, IGLL1, CD79A, CD79B, BLNK,
ICOS, CD19, CD81, TNFRSF13B (TACI), and TNFRSF13C (BAFFR). In addition,
endocrinopathy candidiasis ectodermal dystrophy (APECED) was excluded by sequencing the AIRE gene (Kisand et al. 2010 ). Moreover, FOXP3 was wild-type.
Detection of regulatory T cells and gene expression
FACS analysis using FOXP3 staining revealed a low percentage of Tregs 
Clinical course
Medical history, clinical presentation, and results from laboratory tests led to the clinical diagnosis of chronic mucocutaneous candidasis (CMC) with common variable immunodeficiency (CVID), and treatment with prophylactic fluconazol, trimethoprim/sulfmethoxazole and intravenous immunglobulins (IVIG) was initiated.
During the following months, the clinical condition of the child improved and his susceptibility to upper respiratory infections declined, although he still suffered from several episodes of oral candidiasis, aphthous stomatitis and bacterial keratoconjunctivitis.
Discussion
In the present case report, we describe the phenotype of a 10-year-old boy presenting with recurrent mucosal Candida infections, failure to thrive and cognitive retardation, in whom we identified a heterozygous mutation (c.514T>C, infusions, our patient still suffers from a severe clinical phenotype with dystrophy and delayed neurocognitive development. A similar mutation has been described in a 25-year-old woman born to non-consanguineous parents without a family history of fungal infections or autoimmunity, who presented with disseminated and relapsing histoplasmosis in childhood and later developed chronic and recurrent oral, cutaneous and vaginal candidiasis (Sampaio et al. 2013 ).
The phenylalanine residue at position 172 in the STAT1 coiled-coil domain binds with its aromatic side chain to a pocket in the DNA-binding domain of the partner protomer located at the dimer interface which is required for the formation of antiparallel homodimers (Zhong et al. 2005; Mertens et al., 2006; Staab et al. 2013) ( Fig. 1D ). Due to steric hindrance, substitution of either leucine or tryptophan for phenylalanine critically impairs the stability of the antiparallel dimer conformation and shifts the equilibrium to the parallel conformation. In the parallel conformer, the 
